baber/WOPTO huggingface dataset:
Patent FI-944112-A0 (FI)
Inventor: KUNERT HEINZ
IPC: E06B3/67
Filed: 1994-09-07
Abstract: PCT No. PCT/EP94/00068 Sec. 371 Date Sep. 12, 1994 Sec. 102(e) Date Sep. 12, 1994 PCT Filed Jan. 11, 1994 PCT Pub. No. WO94/15784 PCT Pub. Date Jul. 21, 1994.The glazing element in accordance with the invention comprises in its simplest form a pane and a textile spacer fabric arranged at the covering surface of the pane. The spacer fabric comprises at least two covering layers, which are connected together by rib fibers extending approximately transversely in relation to the panes. The glazing element in accordance with the invention possesses thermal insulating properties and may be utilized as safety glass, more particularly for roofs or overhead glazing arrangements.
Patent FI-953565-A0 (FI)
Inventor: DAHLBAECK BJOERN
IPC: C12Q1/68
Filed: 1995-07-26
Abstract: Methods are disclosed for determining, in a sample derived from a human, the functional activity of a component of the human blood coagulation system, which activity can be correlated to conversion of a substrate specific for activated Protein C (APC), by measuring in an assay medium containing the sample and a substrate for APC, the conversion of the substrate by APC and correlating the conversion to the functional activity of the component. When the component is anticoagulant Factor V, at least one of exogenous APC, Protein S or an inhibitor of Protein S activity is added to the medium. When the component is Protein C, APC, or Protein S, exogenous anticoagulant Factor V or an inhibitor of anticoagulant activity of Factor V is added to the medium. Methods are also disclosed for diagnosing a blood coagulation/anticoagulation disorder or for determining a predisposition thereto in a human by determining anticoagulant Factor V activity in an assay medium containing a sample derived from the human.
Patent FI-970565-A0 (FI)
Inventor: DEUTSCH PAUL J
IPC: C07D277/22
Filed: 1997-02-10
Abstract: The combination of the HIV protease inhibitor Compound J and any one or more of four other potent HIV protease inhibitors is useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Patent FI-972111-A0 (FI)
Inventor: ANDELA CARL SIDONIUS MARIA
IPC: C11D17/00
Filed: 1997-05-16
Abstract: The present invention relates to coated enzyme granules and a method of preparing coated enzyme granules including the steps of (i) contacting enzyme granules with a coating material which is either (a) a non-aqueous liquid or aqueous emulsion thereof, or (b) an unctuous mixture comprising at least one liquid as in (a) having dissolved therein a second component having a melting point in the range 30 to 90  DEG C, said contacting being carried out so as to provide a substantially uniform coating on said granules of said coating material at less than 25 wt.%, and (ii) contacting the granules formed in step (i) with an anti-caking agent so as to obtain free-flowing granules having a dust figure of less than 2  mu g as determined by the Heubach attrition test.
Patent IL-70174-A0 (IL)
Title: Green-house curtain
IPC: A47H23/08
Filed: 1983-11-09
Abstract: A green-house curtain in which the connecting part consists of textile threads (15, 16) and the covering part mainly consists of foil strips (10) of a material which reflects and/or absorbs heat radiation. The foil strips are arranged tightly edge to edge and form an essentially unbroken connected surface, and the connecting threads extending in the longitudinal direction of the material path are preferably located on one of the sides, the underside, of the fabric.
Patent IL-73428-A0 (IL)
Title: Anti-idiotype antibodies against a tumor or virus,method and cell lines for producing them and compositions containing them
IPC: C12P21/08
Filed: 1984-11-05
Abstract: Anti-idiotype antibodies, their production and their use in inducing an immunological response to viruses.
Patent IL-74144-A0 (IL)
Title: Method of concentrating and detecting biomolecules and-cells and means therefor
IPC: C12Q1/68
Filed: 1985-01-23
Abstract: A method of detecting biological substances having affinity properties by passing the substance to be detected in a flow over a solid surface to which surface a second substance, to which the substance to be detected shows affinity, is attached, so that the two substances form a complex and give enrichment of the substance to be detected. 
<??>A means for detecting biological substances consisting of a flow of a fluid sample of the substance to be detected generated via a pump over a solid surface to which another substance, to which the first substance to be detected shows affinity, is attached, so that a complex is formed of the two substances and gives enrichment of the substance to be detected.
Patent IL-78139-A0 (IL)
Title: Herbicidal and insecticidal compositions containing pyrazole derivatives,certain such novel compounds and their preparation
IPC: A01N43/56
Filed: 1986-03-13
Abstract: Herbicidally and insecticidally active 4-nitro-1-phenylpyrazoles of the formula   <IMAGE>   in which R1 and R2 each independently is hydrogen, alkyl, cycloalkyl, hydroxyalkyl, alkoxyalkyl, alkylthioalkyl or halogenoalkyl, R3, R4, R5, R6 and R7 each independently is hydrogen, halogen, cyano, nitro, alkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, alkoxycarbonyl, or -(X)n-R8, X is oxygen, sulphur, sulphinyl or sulphonyl, n is 0 or 1, and R8 is halogenoalkyl.
Patent IL-85439-A0 (IL)
Title: Robotic or remotely controlled flying platform
IPC: B64C27/20
Filed: 1988-02-16
Abstract: A flying platform (10), propelled by at least one ducted fan (11) causing a vertically downwardly directed airstream in and through a cylindrical duct (12). A vane system in the duct (12) has two mutually perpendicular pairs (31-34) of diametrically opposite first vanes, each extending in from the duct rim toward the center of the duct. Each pair of first vanes provides a pair of generally vertical walls parallel to a diametral line across the duct, and they define duct passages between the pairs of vanes and define quadrants between adjacent pairs. Each first vane has an upper, fixed, rigid portion and a variable camber flap (45, 46) depending therefrom. A first servomotor with linkages vary the camber of each pair of flaps (45, 46), so that the camber of the flaps (45, 46) of each pair is at all times the same amount but in opposite directions. Preferably, there are also four second vanes (41-44), one bisecting each quadrant, and a symmetric pair of spoilers (75-82) is mounted on each second vane (41-44). Each pair of spoilers (75-82) is independently movable, as a pair continuously between a position substantially blocking airflow through the outer portion of said quadrant and a position permitting substantially full airflow therethrough. A second servomotor with linkages symmetrically varies the position of its spoilers (75-82). There may be a radio receiver responsive to remote control signals for actuating each servomotor and its linkages.
Patent IL-85635-A0 (IL)
Title: N-acetyl-3-fluoro-neuraminic acid derivatives and methods for the preparation thereof
IPC: A61P31/12
Filed: 1988-03-03
Abstract: This invention relates to novel derivatives of N-acetyl-3-fluoro-neurminic acid derivatives (I) and preparation thereof. The compound (I) can be synthesized by reacting a solution of alkyl 5-acetamido-2,6-anhydro-4,7,8,9-tetra-O-acetyl-2,3,5-trideoxy-D-glycer o-D-galact o-2-enonate with (i) an inert gas containing fluorine or (ii) acetylhypofluorite obtained by passing the inert gas containing fluorine through a mixture of acetic acid/acetate by passing thereinto, and then removing a solvent and applying the residue through a silica gel column chromatography.
Patent IL-86878-A0 (IL)
Title: Dyeing textiles in a non-uniform fashion
IPC: D06B19/00
Filed: 1988-06-27
Abstract: A textile dyed in a non-uniform fashion characterized in that it has irregular, random, maculated patterns on its surface which vary in shape, size, intensity of colour shading and/or colour, and which are distributed in a non-uniform fashion over the surface of the textile, whereas other areas are undyed or have a light colour.
Patent IL-92269-A0 (IL)
Title: Pharmaceutical composition for treatment of autoimmune diseases
IPC: A61P29/00
Filed: 1989-11-10
Abstract: A method of treating a human or animal patient suffering from an autoimmune disease comprises daily administration to such patient of from about 1 to about 100 mg of the narcotic antagonists nalmefene or naltrexone. The nalmefene (6-methylene-6-desoxy-N-cyclopropyl-methyl-14--hydroxydihydronormorphine) or naltrexone (N-cyclopropylmethyl--14-hydroxy-dihydromorphinone) may be administered in equally divided doses from one to four times daily, preferably by the oral route. Parenteral administration may be utilized where suitable.
Patent IL-92867-A0 (IL)
Title: N-pyridinyl-9h-carbazol-9-amines,a process for their preparation and their use as medicaments
IPC: A61P25/28
Filed: 1989-12-25
Abstract: The present invention relates to compounds of the formula <CHEM>  where,  X is hydrogen, loweralkyl, loweralkoxy or halogen;  Y is hydrogen, loweralkyl or halogen;  Z is hydrogen, loweralkyl or halogen;  R is hydrogen, loweralkyl, loweralkenyl,  loweralkylcarbonyl, dimethylaminoloweralkyl or <CHEM> m being an integer of 1 to 6, with the proviso that when R is loweralkenyl the double bond is not alpha to the nitrogen atom; and a process for their preparation. The compounds are useful analgesic, anticonvulsant and antidepressant agents, and for treating various memory dysfunctions characterized by decreased cholinergic function such as Alzheimer's disease, and can, therefore, be used as medicaments.
Patent IL-97066-A0 (IL)
Title: Preparation of uracil derivatives
IPC: C07D239/60
Filed: 1991-01-28
Abstract: PCT No. PCT/EP91/00324 Sec. 371 Date Aug. 21, 1992 Sec. 102(e) Date Aug. 21, 1992 PCT Filed Feb. 21, 1991 PCT Pub. No. WO91/13064 PCT Pub. Date Sep. 5, 1991.The present invention relates to a novel process for preparing uracil derivatives useful as intermediates in the synthesis of uridines having antiviral or antitumor activity or useful as coadjuvants in antiviral therapy, characterized by converting a compound of the formula II into its mesylate derivative of the formula III which is the reduced to give the desired compound of the formula I:  (* CHEMICAL STRUCTURE *)  (* CHEMICAL STRUCTURE *)  in which R1 is H, halogen, alkyl, aryl or aralkyl.
Patent SE-9802590-A0 (SE)
Title: Nukleotidsekvenser som markörer för resistens mot potatisvirus Y och metoder för att detektera dess sekvenser
Inventor: VALKONEN JARI PEKKA TAPANI
IPC: C12Q1/686
Filed: 1998-07-20
Abstract: 3 
levts i potatis hittills varit att sadana PCR-baserade markorer inte bar uppfyllt ovan namnda f•5rsta krav. 
SAMMANFATTNING AV UPPFINNINGEN 
Foreliggande uppfinning avser en metod fOr att testa potatislinjer for resistens mot potatisvirus Y sasom definieras i krav 1. Saledes är det ett syfte for foreliggande uppfinning att tillhandahalla en metod for att bestamma narvaron av vissa sekvenser, delar av dessa sekvenser eller sekvenser som är mycket homologa med dessa sekvenser. Primrar for amplifiering av sekvenserna, ldmpliga restriktionsenzymer och hybridiserings-prober tillhandahalls. Sekvenserna amplifieras och identifieras darefter genom en kombinerad restriktionsenzym- och elektroforesanalys. Analysen for bestamning av sekvenserna kan ocksa vara en hybridiseringsanalys. 
Vidare tillhandahalls ett kit fOr att detektera vilken som heist av sekvenserna enligt uppfinningen innefattande primrar och eventuellt restriktionsenzymer eller innefattande hybridiserings-prober. 
DETALJERAD BESKRIVNING AV UPPFINNINGEN 
Foreliggande uppfinning bygger pa faktumet att DNA-sekvenser bar korrelerats till extrem resistens (E) mot potatisvirus Y. Denna typ av resistens ãr kraftig och effektiv mot alla stammar av PVY, sasom de vdrldsomfattande spridda PVY-stamgrupperna PVT) och PVYN (Hamaldinen et al 1998). Extrem resistens skiljer sig fran hyperkanslig resistens (H), som är aktiv mot endast vissa stammar av PVY och undviks av andra PVY-stammar (Jones 1990) och uttrycks inte alltid, beroende pa t. ex. miljobetingelser (Valkonen 1997). Modern molekyldrbiologi tillhandahaller manga tekniker fOr att testa for narvaro av dessa sekvenser. Den fOrdragna metoden for att utfora en &Adana analys ãr baserad pa polymeraskedjereaktionen (PCR) men andra metoder for detektion av dessa DNA-sekvenser är mojliga. Det ãr till exempel mojligt att konstruera DNA till DNA eller RNA till DNA hybridiseringsprober f6r att testa for resistens av ett potatisprov. Det finns ocksâ andra nukleotidamplifieringstekniker som kan anvandas for att amplifiera DNA-sekvenserna eller deras transkript. Det ãr ocksa mOjligt att detektera translationsprodukten fran dessa sekvenser for att bestamma resistens mot potatisvirus Y.
Patent IL-100938-A0 (IL)
Title: Polypeptides and peptides,particularly recombinant polypeptides and peptides,and nucleic acids coding for the same and their use in the diagnosis of tuberculosis
IPC: C07K7/08
Filed: 1992-02-13
Abstract: The invention relates :   to nucleic acids which contain particularly a nucleotide sequence extending from the extremity constituted by the nucleotide at position (1) to the extremity constituted by the nucleotide at position (149) represented on Figure 1,   to the polypeptides coded by said nucleic acids.   The polypeptides of the invention can be used for the diagnosis of tuberculosis, and can also be part of the active principle in the preparation of vaccine against tuberculosis. <IMAGE>
Patent IL-104038-A0 (IL)
Title: Method of controlling functionability of transmission ways of telecommunication signals
IPC: H04M3/30
Filed: 1992-12-09
Abstract: A method is described for testing the operation of transmission links for telecommunications signals in a telephone network, with which the signals of an exchange are fed in as analog signals, are transmitted in a data stream as digital signals between a system unit of the exchange and at least one subscriber and are fed once more as analog signals at the subscriber end from a system unit of the subscriber to a terminal of the subscriber. A transformer with a hybrid circuit, and also A/D converters, a control block and a line codec are provided in both system units between the analog and digital interfaces. A transmitter and a receiver for digital signals are connected in the control block of at least one of the system units to the transmission link of one transmission direction. When the link is checked and an associated activation of the transmitter performed, the transmission link for the data stream of the digital signals is interrupted and at least the hybrid circuit of the system unit whose transmitter is activated is simultaneously disconnected from the analog interface.
Patent IL-106560-A0 (IL)
Title: Sterile package for surgical instruments
IPC: A61B19/02
Filed: 1993-08-02
Abstract: An improved sterile package for surgical instruments. The package is a thermo-formed tray with an outwardly extending flange. The tray is disposed between two layers and heat sealed together about the periphery of the tray.
Patent IL-108846-A0 (IL)
Title: Use of lamortrigine in the treatment of neuro aids
IPC: A61P25/00
Filed: 1994-03-03
Abstract: The invention relates to the application of riluzole or the pharmaceutically acceptable salts of this compound in the treatment of neuro-AIDS.
Patent IL-110804-A0 (IL)
Title: Triphenylmethyl thiazolidine-2, 4-dione derivatives and processes utilizing the same
IPC: C07C235/58
Filed: 1994-08-29
Abstract: Compounds of formula (I) : <CHEM> (in which: R<0> is hydrogen, methyl or hydroxymethyl; R<1> is substituted alkyl; R<2> and R<3> are each hydrogen, halogen, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkyl, nitro, haloalkyl, or substituted alkyl; X is oxygen atom or a sulphur; and Ar optionally substituted phenyl or naphthyl); and pharmaceutically acceptable salts thereof have a variety of valuable pharmaceutical activities, including anti-diabetic and anti-obesity activities; in addition, they are capable of treating or preventing hyperlipemia and hyperglycemia and, by inhibiting the action of aldose reductase, they can also be effective in the treatment and prevention of complications of diabetes.
Patent IL-127208-A0 (IL)
Title: Tonometer
IPC: A61B3/16
Filed: 1997-05-23
Abstract: A tonometer (10), for determining intraocular pressure, has a body, which can be a transparent, substantially tubular body (12). A plunger (28) is located within the body and a coil spring (36) acts between the body and the plunger. A marker (24) member is frictionally retained within the body and is displaced relative to an external scale (20) on the body. In use, the tonometer is brought up against the eyelid (50) of a closed eye and the body displaced relative to the head of the plunger, until the pressure is sufficient to create a pressure phosphene. The device is then removed and the displacement of the marker member, indicative of the applied pressure is read. This reading corresponds to the intraocular pressure. The device may include a return member (49) for returning the marker member to a zero or rest position. <IMAGE>
Patent IL-135487-A0 (IL)
Title: Antimicrobial and antiviral polymeric materials and a process for preparing the same
IPC: C08J5/18
Filed: 2000-04-05
Abstract: The invention provides an antimicrobial and antiviral polymeric material, having microscopic particles of ionic copper encapsulated therein and protruding from surfaces thereof.
Patent IL-137878-A0 (IL)
Title: Shape memory polymers
IPC: C08G81/00
Filed: 1999-02-23
Abstract: Shape memory polymer compositions, articles of manufacture thereof, and methods of preparation and use thereof are described. The shape memory polymer compositions can hold more than one shape in memory. Suitable compositions include at least one hard segment and at least one soft segment. The Ttrans of the hard segment is preferably between -30 and 270° C. At least one of the hard or soft segments can contain a crosslinkable group, and the segments can be linked by formation of an interpenetrating network or a semi-interpenetrating network, or by physical interactions of the blocks. Objects can be formed into a given shape at a temperature above the Ttrans of the hard segment, and cooled to a temperature below the Ttrans of the soft segment. If the object is subsequently formed into a second shape, the object can return to its original shape by heating the object above the Ttrans of the soft segment and below the Ttrans of the hard segment. The compositions can also include two soft segments which are linked via functional groups which are cleaved in response to application of light, electric field, magnetic field or ultrasound. The cleavage of these groups causes the object to return to its original shape.
Patent IL-144523-A0 (IL)
Title: Method and compositions for healing and repair of articular cartilage
IPC: A61L27/38
Filed: 2000-01-31
Abstract: Methods and compositions are provided for the treatment of articular cartilage defects and disease involving the combination of the tissue, such as osteochondral grafts, with active growth factor. The active growth factor is preferably a composition containing at least one bone morphogenetic protein and a suitable carrier. The method results in the regeneration of functional repair of articular cartilage tissue.
Patent IL-153042-A0 (IL)
Title: Defense device, preferably self-defense device and storage unit used therein
IPC: F41H9/10
Filed: 2001-05-23
Abstract: The accumulator unit (1) with a powder, gaseous or liquid material stored in an accumulator space (5). A propellant is ignited by a fuse composition to drive the material through a nozzle unit (3) into free space by a propellant gas after ignition. A closure element (19) in the nozzle entry area prevents material from coming out of the accumulator space without ignition and is released directly after ignition so that no parts of the broken closure element are pushed out of the nozzle unit. A piston (21) in the accumulator space is moved by the propellant gas to drive the material through the nozzle. A pressure relief device co-operates with the piston. An Independent claim is included for a self-defence device including at least one pair of accumulator units.
Patent IL-154318-A0 (IL)
Title: Pharmaceutical compositions for the treatment of movement disorders
IPC: A61P25/16
Filed: 2003-02-06
Abstract: The invention provides a pharmaceutical composition, medical food, dietary supplement or micronutrient for the treatment of a movement disorder comprising an NMDAR agonist or partial agonist as active ingredient therein in combination with a pharmaceutically acceptable carrier.
Patent IL-175847-A0 (IL)
Title: Cyclopentyl derivatives
IPC: A61K31/16
Filed: 2006-05-23
Abstract: This invention is related to novel cyclopentyl derivatives of the following general formula (I) <CHEM> wherein  X is methylene, oxygen, sulphur or a NR<7> group; R<1>   is a straight or branched C1-C8 alkyl or C3-C8 alkenylene or C3-C8 alkynylene chain, optionally substituted with CF3, phenyl, phenoxy or naphthyl, the aromatic rings optionally substituted by one or more C1-C4 alkyl, halogens, trifluoromethyl, hydroxy or C1-C4 alkoxy groups; R<2>, R<3>   are independently hydrogen, a C1-C3 alkyl chain,halogen, trifluoromethyl, hydroxy or C1-C4 alkoxy groups; R<4>, R<5>, R<6>, R<7>   are independently hydrogen or C1-C6 alkyl;  and the pharmaceutically acceptable salts thereof that are active as sodium and/or calcium channel modulators and therefore useful in preventing, alleviating and curing a wide range of pathologies, including, but not limited to, neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases, where the above mechanisms have been described as playing a pathological role.
Patent IL-176152-A0 (IL)
Title: Percutaneous absorption-type pharmaceutical preparation
Filed: 2006-06-06
Abstract: A stable percutaneous absorption-type pharmaceutical preparation for percutaneous administration of selegiline or selegiline hydrochloride, which does not suffer a decrease in the cohesive force of the adhesive layer therein even in the presence of sweat components due to perspiration during wear and which is free from cohesive failure and resultant adhesive remaining when stripped off, is provided. A percutaneous absorption-type pharmaceutical preparation which comprises: a support; and an adhesive layer containing a metal chloride, an adhesive and at least one of (-)-(R)-N,±-dimethyl-N-2-propynylphenethylamine and its hydrochloride, wherein the adhesive layer is subjected to a crosslinking treatment.
Patent IL-178906-A0 (IL)
Title: 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT
IPC: C07D487/04
Filed: 2006-10-26
Abstract: The invention relates to new 7H-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for producing the active agent. The pharmaceutical preparation is adventageously antiphlogistic and analgetic one, a preparation reducing neuropathic hyperalgesia and rheumatic arthritis, a preparation for hindering destruction of bones chondrus, being applicable for treatment of other diseases, which may be connected with other inflammatory processes e.g. asthma, eczema or psoriasis.